PNL18 COST-EFFECTIVENESS OF CONTINUOUS DUODENAL DELIVERY OF LEVODOPA (DUODOPA®) IN PATIENTS WITH SEVERE PARKINSON'S DISEASE
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67557-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)67557-2/fulltext
Title :
PNL18 COST-EFFECTIVENESS OF CONTINUOUS DUODENAL DELIVERY OF LEVODOPA (DUODOPA®) IN PATIENTS WITH SEVERE PARKINSON'S DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67557-2&doi=10.1016/S1098-3015(10)67557-2
First page :
Section Title :
Open access? :
No
Section Order :
131